Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Scientific Reports|October 19, 2022
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patientsKota Iwahori, Takeshi Uenami, Yukihiro Yano, et al.
FEBS Open Bio|June 18, 2013
Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9Ping He, Hanako Kuhara, Isao Tachibana, et al.
Scientific Reports|September 17, 2013
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesisToshiyuki Minami, Takashi Kijima, Satoshi Kohmo, et al.
Clinical Case Reports|February 28, 2022
COVID-19 in a human T-cell lymphotropic virus type-1 carrierTakatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata, et al.
The Journal of Investigative Dermatology|January 24, 2016
Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese PatientsAtsunari Tsuchisaka, Sanae Numata, Kwesi Teye, et al.
Respiratory Medicine|September 11, 2025
Effectiveness of antifibrotic treatment in real-world patients with progressive pulmonary fibrosisTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2025
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter studyAkihiro Tsukaguchi, Kinnosuke Matsumoto, Akihiro Tamiya, et al.
Clinical and Experimental Nephrology|November 7, 2022
Establishment and clinical application of SARS-CoV-2 catch columnYoshitaka Isaka, Taku Yoshiya, Chikako Ono, et al.
RMD Open|January 23, 2023
Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung diseaseTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.
BMC Infectious Diseases|June 24, 2022
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severityYuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Scientific Reports|October 19, 2022
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patientsKota Iwahori, Takeshi Uenami, Yukihiro Yano, et al.
FEBS Open Bio|June 18, 2013
Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9Ping He, Hanako Kuhara, Isao Tachibana, et al.
Scientific Reports|September 17, 2013
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesisToshiyuki Minami, Takashi Kijima, Satoshi Kohmo, et al.
Clinical Case Reports|February 28, 2022
COVID-19 in a human T-cell lymphotropic virus type-1 carrierTakatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata, et al.
The Journal of Investigative Dermatology|January 24, 2016
Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese PatientsAtsunari Tsuchisaka, Sanae Numata, Kwesi Teye, et al.
Respiratory Medicine|September 11, 2025
Effectiveness of antifibrotic treatment in real-world patients with progressive pulmonary fibrosisTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2025
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter studyAkihiro Tsukaguchi, Kinnosuke Matsumoto, Akihiro Tamiya, et al.
Clinical and Experimental Nephrology|November 7, 2022
Establishment and clinical application of SARS-CoV-2 catch columnYoshitaka Isaka, Taku Yoshiya, Chikako Ono, et al.
RMD Open|January 23, 2023
Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung diseaseTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.
BMC Infectious Diseases|June 24, 2022
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severityYuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, et al.
Pageof 15